Global development strategy for companion diagnostics based on the usage and approval history for biomarkers in Japan, the USA and the EU

Personalized Medicine
Nobuyuki Hanamura, Atsushi Aruga

Abstract

The aim of this study was to identify gaps between Japan and the West in biomarker usage and the development of companion diagnostics. We also elaborated potential scenarios for companion diagnostic development. Information on drug labels in Japan, the USA and the EU was obtained from each regulatory authority's web site, as well as label information on in vitro diagnostic testing in Japan and the USA. It is necessary to consider two factors when developing companion diagnostics globally: ethnic differences in gene mutations, and the approach to patient selection in clinical trials. A flowchart covering four scenarios was developed. Two factors that should be taken account when developing companion diagnostics globally was specified. This flowchart is expected to serve as a guide for streaming the development of companion diagnostics.

References

Oct 29, 2010·Clinical Pharmacology and Therapeutics·D K Burns
Oct 29, 2010·Clinical Pharmacology and Therapeutics·M Pirmohamed
Nov 18, 2010·Clinical Pharmacology and Therapeutics·R D Hockett, S L Close
Dec 15, 2010·Pharmacogenomics·Lois M HinmanWilliam Pignato
Dec 28, 2011·Drug Metabolism and Pharmacokinetics·Yasuto OtsuboYoshiaki Uyama
Mar 1, 2012·Nature Reviews. Clinical Oncology·Eric H Rubin, D Gary Gilliland
Mar 7, 2012·New Biotechnology·Suzanne ChengLin Wu
Apr 27, 2012·Clinical Pharmacology and Therapeutics·N GreccoUNKNOWN Industry Pharmacogenomics Working Group
Feb 2, 2013·Nature Reviews. Drug Discovery·Marc MaliepaardMarkus Paulmichl
Sep 7, 2013·Nature Reviews. Drug Discovery·Jane FridlyandHoward I Scher
Nov 1, 2011·Personalized Medicine·Richard L Schilsky
Sep 1, 2010·Personalized Medicine·Živana TežakElizabeth Mansfield
Sep 1, 2011·Personalized Medicine·Christopher-Paul Milne, Rachael Zuckerman

❮ Previous
Next ❯

Citations

May 4, 2018·Journal of Clinical Pharmacy and Therapeutics·R Shimazawa, M Ikeda
Mar 1, 2016·Personalized Medicine·Rumiko Shimazawa, Masayuki Ikeda

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

TheraScreen

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Advances in Hematology & Oncology : H&O
Robert Becker, Elizabeth Mansfield
Nihon rinsho. Japanese journal of clinical medicine
Sumimasa Nagai
© 2022 Meta ULC. All rights reserved